Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance
Abroad (travel likely)RecruitingPHASE3
Conditions
HIV-1-infection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya
Bomu Hospital, Mombasa, Kenya
Contact: Study coordinator (Nashina Admani)Kenyatta National Hospital, Nairobi, Kenya
Butha-Buthe District Hospital, Butha-Buthe, Lesotho
Contact: Study coordinator (Irene Ayakaka)Mokhotlong District Hospital, Mokhotlong, Lesotho
Contact: Study coordinator (Irene Ayakaka)CS Ponta Gea, Beira, Sofala, Mozambique
Contact: Study coordinator (Nalia Ismael)CS Machava II, Maputo, Mozambique
Contact: Study coordinator (Nalia Ismael)CS Ndlavela, Maputo, Mozambique
Contact: Study coordinator (Nalia Ismael)MUHAS Clinical Trial Unit, Dar es Salaam, Tanzania
Contact: Study coordinator (Patricia Munseri)
Study leads
Loice A Ombajo, MMed, MSc
Principal Investigator
University of Nairobi